Skip to main content
. Author manuscript; available in PMC: 2022 Mar 18.
Published in final edited form as: Transl Res. 2021 Feb 19;233:77–91. doi: 10.1016/j.trsl.2021.02.009

Fig 4.

Fig 4.

Performance of the protein diagnostic model in the assessment of lung cancer risk in asymptomatic individuals. Probabilities of malignancy were calculated using the regression model generated from the quantification of C4c, CYFRA 21–1 and CRP in plasma samples from asymptomatic individuals who were or were not diagnosed with lung cancer in the context of a CT-screening program (n = 30 and n = 93, respectively). The ROC curve and the AUC obtained from these probabilities are also shown. The P value was calculated using the two-sided Mann-Whitney U test.